ELECTED NOT TO
RECEIVE UT PRODUCT").
DISTRIBUTOR SHALL IMMEDIATELY RECORD THIS INFORMATION.
(II.)
WHEN THE PRESCRIBER IS THE CUSTOMER,
DISTRIBUTOR SHALL ATTEMPT TO CONTACT THE INCLUDED PATIENT ON THE SAME DAY THAT
THE BENEFIT VERIFICATION HAS BEEN COMPLETED FOR THE INCLUDED PATIENT IN ORDER TO
INFORM THE INCLUDED PATIENT OF HIS OR HER COST SHARE AMOUNT, IF ANY, AND TO MAKE
ARRANGEMENTS WITH THE INCLUDED PATIENT FOR COLLECTION SUCH COST SHARE AMOUNT, IF
ANY, AND TO INTRODUCE THE INCLUDED PATIENT TO THE DISTRIBUTOR'S SERVICES.
DISTRIBUTOR MAY DELAY SHIPMENT OF UT PRODUCT UNTIL THE INCLUDED PATIENT'S COST
SHARE AMOUNT IS SATISFIED IN FULL.
DISTRIBUTOR SHALL BE SOLELY RESPONSIBLE FOR
SUBMITTING CLAIMS FOR REIMBURSEMENT DIRECTLY TO THE THIRD-PARTY PAYER FOR THE
APPLICABLE REIMBURSABLE AMOUNT (DEDUCTING ANY INCLUDED PATIENT COST SHARE
AMOUNT).
(III.)
DISTRIBUTOR SHALL DISPENSE THE UNIT(S) OF UT
PRODUCT (ALONG WITH A CURRENT PACKAGE INSERT) TO INCLUDED PATIENTS PURSUANT TO A
VALID PRESCRIPTION AND IN ACCORDANCE WITH APPLICABLE LAWS.
UPON RECEIPT OF A
CLEAN PRESCRIPTION, DISTRIBUTOR SHALL ENSURE THAT THE INCLUDED PATIENT RECEIVES
UT PRODUCT WITHIN ONE (1) BUSINESS DAY FROM RECEIPT OF SUCH PRESCRIPTION, OR AT
SUCH OTHER TIME AS THE INCLUDED PATIENT MAY REQUEST.
(D)
FOLLOW UP ACTIVITY GENERALLY: UNLESS
DISTRIBUTOR IS OTHERWISE REQUIRED TO CONTACT CUSTOMER SOONER OR MORE OFTEN,
DISTRIBUTOR SHALL CONTACT CUSTOMER
TWO (2) BUSINESS DAYS AFTER
RECEIPT OF A PRESCRIPTION/REFERRAL AND EVERY TWO (2) BUSINESS DAYS THEREAFTER TO
UPDATE CUSTOMER ON THE STATUS OF A BENEFITS INVESTIGATION/PRIOR
AUTHORIZATION/APPEAL OR OTHER RELATED MATTER. WHEN REQUIRED TO OBTAIN ADDITIONAL
INFORMATION TO COMPLETE A VALID PRESCRIPTION/COVERAGE DETERMINATION/PRIOR
AUTHORIZATION/APPEAL OR RELATED MATTER, DISTRIBUTOR SHALL COMMUNICATE ALL
REQUIRED INFORMATION TO THE APPROPRIATE PARTY AND CONTINUE TO CONTACT SUCH PARTY
EVERY BUSINESS DAY UNTIL THE NEEDED INFORMATION IS RECEIVED OR THE MATTER IS
OTHERWISE CLOSED.
(A)
SOCIAL SERVICES: DISTRIBUTOR SHALL ENGAGE
IN PATIENT ADVOCACY AND UPON RECEIPT OF INQUIRIES FROM OR CUSTOMERS, PROVIDE
NOTICE TO SUCH CUSTOMERS OF ALTERNATE FUNDING SOURCES, CERTAIN HARDSHIP
REIMBURSEMENT SUPPORT, AND CERTAIN INDIGENT AND PATIENT ASSISTANCE PROGRAMS,
INCLUDING UT'S PAP AS DESCRIBED IN ATTACHMENT C HERETO. DISTRIBUTOR SHALL SEND
AN APPLICATION TO ALL ELIGIBLE INCLUDED PATIENTS WHO REQUEST TO PARTICIPATE IN
THE PAP WITHIN ONE (1) BUSINESS DAY FROM THE DATE OF SUCH REQUEST, WITH NOTICE
TO THE REFERRAL SOURCE (VIA FAX, EMAIL OR MAIL) AS WELL.
(B)
PRODUCT & ANCILLARY SUPPLY DISTRIBUTION:
DISTRIBUTOR SHALL MAKE AVAILABLE AND/OR DISPENSE WITH UT PRODUCT, AS NECESSARY
AND APPROPRIATE FOR THE APPLICABLE SITE OF SERVICE (E.G., HEALTH CARE
PROVIDER/PHYSICIAN OFFICE, CLINIC, HOSPITAL OUTPATIENT SETTING, PHARMACY-OWNED
FACILITY, HOME), THE CONTENTS OF THE UT PRODUCT PACKAGE AND SUPPLIES NECESSARY
FOR UT PRODUCT ADMINISTRATION.
(C)
EDUCATION: DISTRIBUTOR SHALL PROVIDE ITS
STANDARD EDUCATIONAL SUPPORT (INCLUDING THE PROVISION OF ANY UT MATERIALS OR
EDUCATIONAL MATERIALS) REGARDING UT PRODUCT ADMINISTRATION AND SAFETY TO
CUSTOMERS AND CAREGIVERS INVOLVED IN TREATING INCLUDED PATIENTS. DISTRIBUTOR
SHALL PROMPTLY RESPOND TO QUESTIONS FROM MANAGED CARE ORGANIZATIONS AND OTHER
THIRD-PARTY PAYERS ABOUT UT PRODUCT. NOTWITHSTANDING THE FOREGOING, THE
PROVISION OF SUCH EDUCATIONAL SERVICES SHALL BE PERFORMED IN ACCORDANCE WITH THE